CRH and obesity disorder: We hypothesize that the targeted disruption of corticotropin-releasing hormone (CRH) expression within the paraventricular hypothalamic nucleus (PVN) through intracranial AAV8-hSyn-Cre injection in adult animals may result in obesity and metabolic alterations.